发明名称 ESMOLOL FORMULATION
摘要 <p><P>PROBLEM TO BE SOLVED: To provide final sterilization associated with an aqueous, sterile pharmaceutical composition suitable for parenteral administration for treating cardiac conditions. <P>SOLUTION: The aqueous, sterile pharmaceutical composition suitable for parenteral administration for treating cardiac conditions is provided. The composition including methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenyl propionate hydrochloride (esmolol hydrochloride), a buffer agent and an osmotic control agent, and a method for producing the same are disclosed. The composition has a pH between 3.5 and 6.5 and contains a 0.1-500 mg/mL methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenyl propionate hydrochloride (esmolol hydrochloride), 0.01-2 M buffer agent and 1-500 mg/mL osmotic control agent. <P>COPYRIGHT: (C)2010,JPO&INPIT</p>
申请公布号 JP2010024249(A) 申请公布日期 2010.02.04
申请号 JP20090252474 申请日期 2009.11.02
申请人 BAXTER INTERNATL INC 发明人 LIU JIE;PEJAVER SATISH K;OWOO GEORGE
分类号 A61K9/08;A61K31/216;A61K9/00;A61K31/24;A61K47/02;A61K47/10;A61K47/12;A61K47/18;A61K47/24;A61K47/26;A61K47/36;A61P9/00;A61P9/10;A61P43/00 主分类号 A61K9/08
代理机构 代理人
主权项
地址